CAMZYOS mavacamten 2.5 mg capsule blister pack

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f1bd4bf70f10aee1
Product Name: CAMZYOS mavacamten 2.5 mg capsule blister pack
Artg Id: 386129
Artg Name: CAMZYOS mavacamten 2.5 mg capsule blister pack
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2022-09-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a9ff149dc6dab2451ff16b9228316733.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/89f108f47aa79ce64213da78a48a8400.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f1bd4bf70f10aee1

Type

Standard